Alimera

(PRESS RELEASE)ATLANTA, GA — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, announced that the company launched new corporate branding and has moved its global headquarters to a […]